Functional Ability, Symptoms and Quality of Life in Patients With Post Covid-19 Condition
LC-cohort
What is the Prognosis of Functional Ability, Symptoms and Quality of Life in Patients That Are Treated in a University Hospital Because Symptoms of Post Covid-19 Condition
1 other identifier
observational
400
1 country
1
Brief Summary
Up to 20% of patients with Covid-19 develop symptoms that last more than 3 months, which is known as long Covid or Post-Covid-19 condition. The mechanism of the long term symptoms is not totally understood although inflammation, autoimmune reactions and thromboembolism are among suspected contributors. At Helsinki University hospital, a long Covid clinic was opened in June 2021. The aim of this cohort study is to monitor the patients that attend the clinic, follow up their functional abilities, quality of life and prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2021
CompletedFirst Submitted
Initial submission to the registry
January 24, 2022
CompletedFirst Posted
Study publicly available on registry
January 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJanuary 26, 2023
January 1, 2023
2.5 years
January 24, 2022
January 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline of WHODAS2.0 questionnaire as measured at 12 months
Functional ability measured by WHODAS2.0 which is a measure developed by WHO and has 36 items. The minimum value is 0, the maximum value is 100. Higher score means worse functional ability.
0, 3, 6, and 12 months
Secondary Outcomes (8)
EUROHIS-8 Quality of life
0, 3, 6, and 12 months
Health related quality of life
0, 3, 6, and 12 months
Depression
0, 3, 6, and 12 months
Anxiety
0, 3, 6, and 12 months
Symptom severity
0, 3, 6, and 12 months
- +3 more secondary outcomes
Interventions
Patients receive individual, tailored, multiprofessional rehabilitation
Eligibility Criteria
Patients with symptoms of long Covid that have lasted at least 3 mo after the primary infection
You may qualify if:
- a diagnosed Covid-19 infection at least 3 mo before entry (either PCR positive or antigen test positive or hospitalisation because of Covid-19)
You may not qualify if:
- patients for whom participation would be too exhausting, for example bed patients
- patients who cannot fill in the questionnaires in Finnish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helsinki University Hospital
Helsinki, 00029, Finland
Related Publications (1)
Virrantaus H, Liira H, Posharina T, Sulg A, Mantyla T, Kanerva M, Laakso S, Sainio M, Malmivaara A, Vuokko A, Varonen M, Venalainen M, Arokoski J. Prognosis of patients with long COVID symptoms: a protocol for a longitudinal cohort study at a primary care referred outpatient clinic in Helsinki, Finland. BMJ Open. 2023 Oct 17;13(10):e072935. doi: 10.1136/bmjopen-2023-072935.
PMID: 37848295DERIVED
Biospecimen
CRP, blood count, sedimentation rate, GT, krea, TSH, fasting glucose, ECG, Alat, Afos, K, Na, Ca, Alb, preAlb, B12-TC, cortisole
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helena Liira, MD, PhD
Helsinki University Central Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
January 24, 2022
First Posted
January 26, 2023
Study Start
July 15, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2024
Last Updated
January 26, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share
We have applied for EU Horizon funding and potentially share data in that project.